Home › Compare › ORYX vs MO

ORYX vs MO: Dividend Comparison 2026

ORYX yields 200000000.00% · MO yields 6.27%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ORYX wins by $1.3558155772724413e+43M in total portfolio value
10 years
ORYX
ORYX
● Live price
200000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1.3558155772724413e+43M
Annual income
$13,544,513,988,876,964,000,000,000,000,000,000,000,000,000,000,000.00
Full ORYX calculator →
MO
Altria Group Inc.
● Live price
6.27%
Share price
$67.02
Annual div
$4.20
5Y div CAGR
22.6%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$77.7K
Annual income
$28,968.54
Full MO calculator →

Portfolio growth — ORYX vs MO

📍 ORYX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodORYXMO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ORYX + MO cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
ORYX pays
MO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ORYX
Annual income on $10K today (after 15% tax)
$17,000,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$11,512,836,890,545,420,000,000,000,000,000,000,000,000,000,000,000.00/yr
MO
Annual income on $10K today (after 15% tax)
$532.68/yr
After 10yr DRIP, annual income (after tax)
$24,623.26/yr
At 15% tax rate, ORYX beats the other by $11,512,836,890,545,420,000,000,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ORYX + MO for your $10,000?

ORYX: 50%MO: 50%
100% MO50/50100% ORYX
Portfolio after 10yr
$6.779077886362206e+42M
Annual income
$6,772,256,994,438,482,000,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.90%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MO right now

ORYX
No analyst data
MO
Analyst Ratings
16
Buy
9
Hold
1
Sell
Consensus: Buy
Price Target
$61.25
-8.6% upside vs current
Range: $47.00 — $68.00
Altman Z
3.2
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ORYX buys
0
MO buys
0
No recent congressional trades found for ORYX or MO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricORYXMO
Forward yield200000000.00% ✓6.27%
Annual dividend / share$2.00$4.20 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%22.6% ✓
Portfolio after 10y$1.3558155772724413e+43M$77.7K ✓
Annual income after 10y$13,544,513,988,876,964,000,000,000,000,000,000,000,000,000,000,000.00 ✓$28,968.54
Total dividends collected$1.3557262927128971e+43M$72.0K ✓
Payment frequencyquarterlyquarterly
SectorStockConsumer Staples

Year-by-year: ORYX vs MO ($10,000, DRIP)

YearORYX PortfolioORYX Income/yrMO PortfolioMO Income/yrGap
1← crossover$10,000,010,700$10,000,000,000.00$10,558$768.31+$10000.00M → ORYX
2$4,672,912,896,273,132$4,672,902,196,261,683.00$11,352$1,015.87+$4672912896.26M → ORYX
3$1,020,380,774,379,872,600,000$1,020,375,774,363,073,600,000.00$12,482$1,367.86+$1020380774379872.63M → ORYX
4$104,117,924,275,745,270,000,000,000$104,116,832,468,316,660,000,000,000.00$14,103$1,883.39+$104117924275745259520.00M → ORYX
5$4,964,553,026,072,278,600,000,000,000,000$4,964,441,619,893,303,400,000,000,000,000.00$16,472$2,664.91+$4.964553026072278e+24M → ORYX
6$110,619,615,037,467,830,000,000,000,000,000,000$110,614,302,965,729,920,000,000,000,000,000,000.00$20,024$3,897.79+$1.1061961503746783e+29M → ORYX
7$1,151,845,242,391,102,900,000,000,000,000,000,000,000$1,151,726,879,403,013,000,000,000,000,000,000,000,000.00$25,537$5,933.74+$1.151845242391103e+33M → ORYX
8$5,605,227,219,644,151,000,000,000,000,000,000,000,000,000$5,603,994,745,234,793,000,000,000,000,000,000,000,000,000.00$34,478$9,476.77+$5.605227219644151e+36M → ORYX
9$12,749,330,698,549,516,000,000,000,000,000,000,000,000,000,000$12,743,333,105,424,497,000,000,000,000,000,000,000,000,000,000.00$49,776$16,022.63+$1.2749330698549515e+40M → ORYX
10$13,558,155,772,724,413,000,000,000,000,000,000,000,000,000,000,000$13,544,513,988,876,964,000,000,000,000,000,000,000,000,000,000,000.00$77,699$28,968.54+$1.3558155772724413e+43M → ORYX

ORYX vs MO: Complete Analysis 2026

ORYX — Stock

ORYX is a dividend-paying stock. Use this calculator to estimate your future dividend income, DRIP compounding returns, and passive income potential from investing in ORYX shares.

Full ORYX Calculator →

MO — Consumer Staples

Altria Group, Inc., through its subsidiaries, manufactures and sells smokeable and oral tobacco products in the United States. The company provides cigarettes primarily under the Marlboro brand; cigars and pipe tobacco principally under the Black & Mild brand; and moist smokeless tobacco products under the Copenhagen, Skoal, Red Seal, and Husky brands, as well as provides on! oral nicotine pouches. It sells its tobacco products primarily to wholesalers, including distributors; and large retail organizations, such as chain stores. Altria Group, Inc. was founded in 1822 and is headquartered in Richmond, Virginia.

Full MO Calculator →
📬

Get this ORYX vs MO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ORYX vs SCHDORYX vs JEPIORYX vs OORYX vs KOORYX vs MAINORYX vs PMORYX vs BTIORYX vs PG

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.